STOCK TITAN

Alnylam Pharmaceuticals, Inc. (ALNY) Free Cash Flow by Year

ALNY

Alnylam Pharmaceuticals, Inc. generated $465.4M in free cash flow in fiscal year 2025. This represents an increase of 1192.7% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Alnylam Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow $465.4M
YoY +1192.7%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ALNY Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Free Cash Flow$465.4M+1192.7%-$42.6M-201.5%$41.9M+106.8%-$613.3M+14.6%-$718.1M-4.8%-$685.3M-63.7%-$418.6M+39.3%-$689.5M-41.6%-$487.0M-30.8%-$372.3M-84.2%-$202.1M-15.7%-$174.6M-140.3%-$72.7M+41.4%-$124.0M-40.3%-$88.4M

ALNY Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Free Cash FlowN/AN/A$140.3M+235.2%$338.9M+757.6%N/AN/A-$103.8M-130.0%$39.5M-88.5%$116.1M+255.0%-$94.5M+47.6%-$45.1M+70.6%$342.3M+359.7%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Alnylam Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Alnylam Pharmaceuticals, Inc.'s free cash flow in fiscal year 2025?

Alnylam Pharmaceuticals, Inc. generated $465.4M in free cash flow in fiscal year 2025.

How fast is Alnylam Pharmaceuticals, Inc.'s free cash flow growing?

Alnylam Pharmaceuticals, Inc. (ALNY) free cash flow rose by 1192.7% year over year, from -$42.6M to $465.4M in fiscal year 2025.

How has Alnylam Pharmaceuticals, Inc.'s free cash flow changed over the years?

Across the 15 fiscal years this page covers, Alnylam Pharmaceuticals, Inc. (ALNY) free cash flow went from -$88.4M in fiscal year 2011 to $465.4M in fiscal year 2025.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Alnylam Pharmaceuticals, Inc. (ALNY) reported on that line in every period on record.